Medical News

RSS

Dental therapy that regenerates the tooth enamel rather than drilling

Unlike skins or bones, the tooth enamel, which forms the hard surface of a tooth, does not regenerate itself once damaged. Therefore, the conventional dental treatment includes drilling of the decayed part of a tooth and filling the hole with resin or metal alloy dental materials.

24 Feb 2005

Control and containment key to combating avian influenza

Containing the bird flu virus to the greatest extent possible and reducing the risk of infection in poultry and farmed free-range ducks will help to prevent a global human influenza pandemic, the Food and Agriculture Organization (FAO) has announced.

24 Feb 2005

$71 million to launch a new drug

Mid-level pharmaceutical brands invest an average of $71 million in marketing between Phase III trials and the first year on the market, according to a new report from Cutting Edge Information.

24 Feb 2005

Should screening for sleep apnea be required for all men?

According to a new study, men in their 20s need to be screened the most. That's because men aged 20 to 29 with severe sleep apnea have 10 times the risk of dying from heart related ailments than their non sleep apnea peers in the general population, and a much higher risk than older men with sleep apnea.

24 Feb 2005

Trial results on the use of recombinant activated factor VII in acute intracerebral haemorrhage

The New England Journal of Medicine (NEJM) today reports positive results from the recently completed clinical trial of recombinant activated factor VII (NovoSeven/rFVIIa) in intracerebral haemorrhage (ICH).

24 Feb 2005

Sexual banter in the workplace is OK, sex might be an issue though!

Sexualized encounters in some work situations actually can contribute to building camaraderie in a workforce, according to a new study by a University of Washington, Bothell, sociologist who examines sexual banter and power in the workplace.

24 Feb 2005

Counseling smokers to quit reduced their chances of dying

Giving up smoking after a heart attack has been clearly associated with improvements in long-term patient survival, but how soon after myocardial infarction does smoking cessation begin to have positive effects?

24 Feb 2005

New imaging method that may provide a clearer diagnosis of breast cancer

"This technique involves a new method for interpreting information gathered through MRI," explained Springer. "The technique involves recognizing that certain properties of MRI signals can change during the examination, much like the changing of a camera's shutter speed.

24 Feb 2005

$Osteochondral allograft and microfracture procedures restore patient mobility$

Osteochondral allograft and microfracture procedures restore patient mobility

Two separate new studies presented at a major medical meeting provide objective scientific evidence that the two most commonly performed cartilage repair techniques are effective at restoring patient mobility and reducing pain.

24 Feb 2005

Scientists have regenerated a damaged optic nerve

This achievement, which occurred in laboratory mice and is described in the March 1, 2005 issue of the Journal of Cell Science, holds great promise for victims of diseases that destroy the optic nerve, and for sufferers of central nervous system injuries.

24 Feb 2005

Experts on chronic lymphocytic leukemia (CLL) review current scientific knowledge

When the most common adult leukemia in the United States was last reviewed by the New England Journal of Medicine (NEJM) in 1995, it was seen through the eyes of theories that dated back to the 1960s.

24 Feb 2005

Protein called CK2 plays a deadly role in colorectal carcinoma

A protein called CK2 plays a deadly role in colorectal carcinoma by blocking the ability of these tumors to activate a natural self-destruct mechanism that would clear this cancer from the body. This finding, by researchers at St. Jude Children's Research Hospital, is currently published in the online edition of Oncogene.

24 Feb 2005

Cutting edge technology identifies genes that are involved in the development of Alzheimer's disease

Phoenix-Researchers at the Translational Genomics Research Institute (TGen) and Kronos Science Laboratories, an affiliate of Phoenix-based Kronos Optimal Health Company, have initiated a study with unprecedented power to identify genes that are involved in the development of Alzheimer's disease, the most common form of disabling memory and thinking problems in older persons.

24 Feb 2005

Mathematical model describes the electrical storm that rages during a brain seizure

"We're trying to get to the underlying state of the brain that leads to these seizures," said Mark Kramer, a Ph.D. student in UC Berkeley's Applied Science and Technology Program and lead author of the paper. "Our hope is that the model can highlight potential areas where a seizure can be stopped."

24 Feb 2005

Common clinical problem, Rosacea

A number of clinical symptoms and signs are included under the broad group Rosacea. Facial flushing, the appearance of broken blood vessels and persistent redness of the face, eruption of inflamed spots & pimples, on the face and thickening of the sebaceous glands of the nose, with swelling & congestion in that area.

24 Feb 2005

Herpesviruses are everywhere!

A population-based study of primary human herpesvirus 6 infection is reported in the current issue of the The New England Journal of Medicine (NEJM).

24 Feb 2005

Discovery could lead to the prevention, and possibly treatment of autoimmune diseases such as Type 1 diabetes

Scientists at the University of Maryland School of Medicine in Baltimore have identified a way to prevent Type I diabetes in rats that are genetically prone to develop the disease.

23 Feb 2005

South Africa explores faith-based healing

The South African Department of Health met with religious leaders in Johannesburg on Monday (21 February 2005) to discus areas of cooperation between the Department and faith-based organisations in improving health of South African nation.

23 Feb 2005

FDA approves Atacand (candesartan cilexetil) for the treatment of heart failure

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved its angiotensin receptor blocker (ARB) Atacand (candesartan cilexetil) Tablets for the treatment of heart failure (NYHA class II-IV and ejection fraction less than or equal to 40%) to reduce the risk of death from cardiovascular causes and reduce hospitalizations for heart failure.

23 Feb 2005

Microsoft combs through millions of strains of human immunodeficiency virus (HIV)

Microsoft Research has pioneered promising new ways to combat one of humankind's most deadly viruses with advanced software typically used to analyze large computer databases and complex digital images, or to separate spam from legitimate e-mail.

23 Feb 2005